Magnetar Financial’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CXAC.WS
RCM
LP
BFM
SCM
GAM
SCM
LA
AA
PAMP
Magnetar Financial's CXAC.WS Position: Q4 2022 in Review
Magnetar Financial sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q4 2022, closing a stake of 181,550 shares — an estimated $20K sold.
Magnetar Financial first reported a position in CXAC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $20K in Q3 2022. 43 funds tracked by Wall St. Rank hold CXAC.WS as of Q4 2022.
- Magnetar Financial reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Magnetar Financial sold 181,550 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $20K.
- Magnetar Financial first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 2 quarters.
- Magnetar Financial's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $20K in Q3 2022.
- 43 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2022.
Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.